共 47 条
The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion
被引:84
作者:
Chand, A. L.
[1
]
Herridge, K. A.
[1
,2
]
Thompson, E. W.
[3
,4
]
Clyne, C. D.
[1
,2
]
机构:
[1] Prince Henrys Inst, Canc Drug Discovery Lab, Melbourne, Vic 3168, Australia
[2] Monash Univ, Dept Biochem, Melbourne, Vic 3168, Australia
[3] St Vincents Inst, Invas & Metastasis Lab, Dept Surg, Melbourne, Vic 3065, Australia
[4] Univ Melbourne, St Vincents Hosp, Melbourne, Vic 3065, Australia
基金:
英国医学研究理事会;
关键词:
STEROIDOGENIC FACTOR-I;
E-CADHERIN EXPRESSION;
CELL-CYCLE;
ESTROGEN BIOSYNTHESIS;
AROMATASE EXPRESSION;
HOMOLOG-1;
LRH-1;
LIVER;
PROSTATE;
METABOLISM;
TARGET;
D O I:
10.1677/ERC-10-0179
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 [肿瘤学];
摘要:
The orphan nuclear receptor liver receptor homologue-1 (LRH-1) has roles in the development, cholesterol and bile acid homeostasis, and steroidogenesis. It also enhances proliferation and cell cycle progression of cancer cells. In breast cancer, LRH-1 expression is associated with invasive breast cancer; positively correlates with ER alpha status and aromatase activity; and promotes oestrogen-dependent cell proliferation. However, the mechanism of action of LRH-1 in breast cancer epithelial cells is still not clear. By silencing or over-expressing LRH-1 in ER-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells, we have demonstrated that LRH-1 promotes motility and cell invasiveness. Similar effects were observed in the non-tumourigenic mammary epithelial cell line, MCF-10A. Remodelling of the actin cytoskeleton and E-cadherin cleavage was observed with LRH-1 over-expression, contributing to increased migratory and invasive properties. Additionally, in LRH-1 over-expressing cells, the truncation of the 120 kDa E-cadherin to the inactive 97 kDa form was observed. These post-translational modifications in E-cadherin may be associated with LRH-1-dependent changes to matrix metalloproteinase 9 expression. These findings suggest a new role of LRH-1 in promoting migration and invasion in breast cancer, independent of oestrogen sensitivity. Therefore, LRH-1 may represent a new target for breast cancer therapeutics. Endocrine-Related Cancer (2010) 17 965-975
引用
收藏
页码:965 / 975
页数:11
相关论文

